top of page


We partner and collaborate with other innovator Research & Development companies to co-develop therapeutic and preventative drug, biologic and medical device products in the clinical phase of the development process. 

Our team members have extensive clinical development experience in the following therapeutic areas:

  • Cardiovascular Diseases

  • Dermatology

  • Oncology

  • Endocrinology

  • Gastroenterology

  • Nephrology

  • Hematology

  • Neurology

  • Oncology

  • Ophthalmology

  • Urology

  • Pain Management

  • Immunology / Autoimmune

  • Pulmonary / Respiratory

  • Psychiatry

  • Rheumatology

  • Infectious Diseases

  • Central Nervous System


Development of safe drugs, biologics, medical devices and vaccines is critical to their pre- and post-approval therapeutic success. Over two decades of experience working directly with the US FDA and Health Canada has greatly enhanced our expertise in the areas of clinical development and drug safety.  


In addition to the United States Food and Drug Administration (FDA) and Health Canada, the DELTA team also has experience in working with the European Medicines Agency (EMA), Ministry of Health Mexico, Argentina Administración Nacional de Medicamentos, Alimentos y Tecnología Médica (ANMAT) and the Ministry of Health Türkiye. ​

bottom of page